
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
A study from the Centers for Disease Control and Prevention found that over 7,000 emergency room visits per year could be attributed to improper use of over-the-counter cough and cold medications...






